March 15, 2013

Stop Alzheimer's Before Symptoms Start? - Dr. Reisa Sperling

Thumbnail

Stop Alzheimer's Before Symptoms Start? - Dr. Reisa Sperling

About This Episode

Dr. Sperling is leading a groundbreaking new study on individuals whose brain scans show plaque buildups but do not yet demonstrate clinical symptoms of Alzheimer’s or other dementias. She will be testing the effectiveness of the Eli Lilly drug solanezumab, which in previous studies has shown might have promise with people that have a milder form of Alzheimer’s.

Dr. Sperling is the Director of the Center for Alzheimer's Research and Treatment, the Director of the Education and Information Transfer Core, Massachusetts Alzheimer's Disease Research Center, Co-Leader of the Neuroimaging Program, Massachusetts Alzheimer's Disease Research Center, and a Professor of Neurology at Harvard Medical School.

This call was made possible by the generous support of Jill Lesser, Board member of USAgainstAlzheimer's Network.

BrainStorm Feed

90

The Longevity Paradox: Health Span vs. Life Span with Paul Irving

What's the purpose of a long life if our brains can't enjoy it? Paul Irving, Senior Advisor at the Milken Institute on the Future of Longevity and Dean of Faculty at USC's Leonard Davis School of Gerontology, challenges conventional thinking about aging and longevity in a conversation with host, Meryl Comer.
LISTEN NOW
89

Paul Irving and The Invisible Workforce: Why Caregiving is a Personal and an Economic Crisis

In this episode of BrainStorm, Paul Irving discusses the PBS documentary produced by Bradley Cooper called Caregiving with host Meryl Comer.
LISTEN NOW
88

Breaking the Silence: Jay Reinstein’s Mission to End Alzheimer's Stigma

In this episode of BrainStorm, host Meryl Comer talks with Jay Reinstein, a former assistant city manager in North Carolina, about his 12 to15-month journey involving neuropsychological testing and brain scans before being diagnosed with early-onset Alzheimer's at age 57.
LISTEN NOW